A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/1997
10/15/1997	EP0800504A1 Tricyclic retinoids, methods for their production and use
10/15/1997	EP0800503A1 Novel trienoic retinoid compounds and methods
10/15/1997	EP0800400A1 Germanium yeast human diet nutritional supplement
10/15/1997	EP0800391A1 Benzimidazoles as inhibitors of calcitriol metabolism
10/15/1997	EP0800389A1 Novel compounds
10/15/1997	EP0772396A4 Method of regulating immune function
10/15/1997	EP0537269B1 Immunosuppressive compounds
10/15/1997	EP0460178B1 Cd4 specific recombinant antibody
10/15/1997	CN1162335A Modified human C3 proteins
10/15/1997	CN1162265A Novel cyclosporine preparation forms for oral administration of simple composition and high bio-availability and process for producing them
10/14/1997	USRE35631 Reacting 3-bromopropylphthalimide with ethylacetoacetate, then with diazonium salt of p-anisidine yields an indole which is treated with sodium hydroxide and sulfuric acid, then hydrolysis and treatment with acetic anhydride
10/14/1997	US5677451 Controlling cell differentiation; skin disorders; anticancer agents
10/14/1997	US5677429 Vaccine
10/14/1997	US5677319 Thiazole derivative
10/14/1997	US5677295 Immunosuppresive, antiinflammatory agnet, fungicides, antituor agents
10/14/1997	US5677283 Antiinflammatory agents, nervous system disorders
10/14/1997	US5677165 Anti-CD40 monoclonal antibodies capable of blocking B-cell activation
10/14/1997	US5676940 Method of reducing immunoglobulin E responses
10/09/1997	WO1997037016A1 Modulators of tnf receptor associated factor (traf), their preparation and use
10/09/1997	WO1997037000A1 Animal cells and processes for the replication of influenza viruses
10/09/1997	WO1997036932A1 Modified/chimeric superantigens and their use
10/09/1997	WO1997036926A1 Growth differentiation factor-14
10/09/1997	WO1997036922A1 Inhibitor and stimulator of stem cell proliferation and uses thereof
10/09/1997	WO1997036914A1 High molecular weight surface proteins of non-typeable haemophilus
10/09/1997	WO1997036904A1 Mitomycin c derivative and non-receptor tyrosine kinase inhibitor
10/09/1997	WO1997036871A1 6-phenylpyridyl-2-amine derivatives
10/09/1997	WO1997036611A1 Cyclosporin emulsions
10/09/1997	WO1997036601A1 Cyclic peptide vaccines for treatment and prevention of diabetes
10/09/1997	WO1997036497A2 Cocoa extract compounds and methods for making and using the same
10/09/1997	WO1997036495A1 Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof
10/09/1997	CA2259133A1 High molecular weight surface proteins of non-typeable haemophilus
10/09/1997	CA2250814A1 Cyclic peptide vaccines for treatment and prevention of diabetes
10/09/1997	CA2250110A1 Growth differentiation factor-14
10/09/1997	CA2249716A1 Inhibitor and stimulator of stem cell proliferation and uses thereof
10/08/1997	EP0799893A1 Defective viral particles obtained in vivo or ex vivo as vaccine
10/08/1997	EP0799873A1 Composition for a non-wettable coating, process for treating glazing pane with this composition and the products obtained
10/08/1997	EP0799620A1 Cyclosporin emulsions
10/08/1997	EP0799578A2 Combined preparation containing electrolyte enriched germs
10/08/1997	EP0799316A1 Recombinant proteinase from clostridium hystolyticum and the use thereof for isolating cells and cell groups
10/08/1997	EP0799311A1 Human chemokine beta-9
10/08/1997	EP0799241A1 Peptides having immunomodulatory activity
10/08/1997	EP0799188A2 Amides of mono and bicarboxylic acids with amino acids or glycosamines, selectively active on the cannabinoid peripheral receptor
10/08/1997	EP0799186A1 1,4,4-(trisubstituted)cyclohex-1-ene dimers and related compounds
10/08/1997	EP0799185A1 1,3,3-(trisubstituted)cyclohexane dimers and related compounds
10/08/1997	EP0799184A1 4,4-(disubstituted)cyclohexan-1-ol dimers and related compounds
10/08/1997	EP0799182A1 3,3-(disubstituted)cyclohexan-1-ol dimers and related compounds
10/08/1997	EP0799181A1 3,3-(disubstituted)cyclohexan-1-carboxylate dimers and related compounds
10/08/1997	EP0799176A1 4,4-(disubstituted)cyclohexan-1-one dimers and related compounds
10/08/1997	EP0799053A1 Enhanced immunogenic vaccine
10/08/1997	EP0799046A1 Stable solutions of 2-chloro-2'-deoxyadenosine
10/08/1997	EP0799044A2 Topical ophthalmic formulations containing doxepin derivatives for treating allergic eye diseases
10/08/1997	EP0799040A1 Trisubstituted thioxanthines
10/08/1997	EP0799037A1 Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
10/08/1997	EP0799036A1 4,4-(disubstituted)cyclohexan-1-ylidine acetate dimers and related compounds
10/08/1997	EP0799033A1 Use of mono and bicarboxylic acid amides for the manufacture of a medicament active at the peripheral cannabinoid receptor
10/08/1997	EP0799031A1 1,4,4-(trisubstituted)cyclohexane dimers and related compounds
10/08/1997	EP0799023A1 Use of flavonoids as immunomodulating or immuno-protective agents in cosmetic and dermatological preparations
10/08/1997	EP0799022A1 Use of flavonoids for protecting unstable cosmetic active substances and constituents in cosmetic and dermatological formulations
10/08/1997	EP0799020A1 Cosmetic and dermatological preparations with flavonoids
10/08/1997	EP0596118B1 Fr901451 substance, process for preparation thereof and use thereof
10/08/1997	EP0506892B1 Boronated nucleosides
10/08/1997	EP0482089B1 Method of treating autoimmune uveoretinitis in human
10/08/1997	CN1161652A Pharmaceutical compositions
10/08/1997	CN1161337A Water soluble rapamycin esters
10/07/1997	US5674978 Peptides derived from glutamic acid decarboxylase
10/07/1997	US5674880 Tri-substituted phenyl derivatives and processes for their preparation
10/07/1997	US5674866 Antiallergic imidazoazepines
10/07/1997	US5674861 Fluorinated steroids
10/07/1997	US5674681 Detecting association of a nonclassical major histocompatibility complex with a beta2 microglobin
10/07/1997	US5674537 Electrolyzed saline solution containing concentrated amounts of ozone and chlorine species
10/07/1997	US5674494 Treating non-malignant disease states with IL-2 receptor-specific substances
10/07/1997	US5674487 Method for treating autoimmune diseases
10/07/1997	CA2041380C Use of protein c or activated protein c for preparing a pharmaceutical preparation
10/07/1997	CA2004154C 3,5-di-tertiary-butyl-4-hydroxyphenyl-1,3,4-thiadiazoles, and oxadiazoles and 3,5-di-tertiary-butyl-4-hydroxyphenyl 1,2,4-thiadiazoles, oxadiazoles and triazoles as anti-inflammatory agents
10/02/1997	WO1997035997A2 Recombinant pox virus encoding myelin protein for therapy
10/02/1997	WO1997035991A1 Soluble divalent and multivalent heterodimeric analogs of proteins
10/02/1997	WO1997035982A2 Monocyte chemotactic protein-5 materials and methods
10/02/1997	WO1997035887A1 Precursors of catalytic antibodies
10/02/1997	WO1997035864A1 Phosphoramidates and phosphinic amides, their use to modulate the activity of endothelin
10/02/1997	WO1997035856A1 Novel treatment for cns injuries
10/02/1997	WO1997035855A1 Novel treatment for cns injuries
10/02/1997	WO1997035854A1 Novel phenanthridines substituted in the 6 position
10/02/1997	WO1997035852A1 Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents
10/02/1997	WO1997035619A1 Opsonin-enhanced cells, and methods of modulating an immune response to an antigen
10/02/1997	WO1997035591A2 Method of treating ciliary dyskinesia with uridine triphosphates and related compounds
10/02/1997	WO1997035581A1 Interleukin-6 production inhibitor
10/02/1997	WO1997035575A1 Use of rapamycin derivatives in vasculopathies and xenotransplantation
10/02/1997	WO1997035572A1 Carboxylic acid indole inhibitors of chemokines
10/02/1997	WO1997035539A2 Arylamino fused pyridines and pyrimidines
10/02/1997	WO1997035538A2 Tumor necrosis factor alpha convertase
10/02/1997	WO1997035480A1 Method of treating common cold or allergic rhinitis
10/02/1997	WO1997013502A3 Prolonged release of gm-csf
10/02/1997	DE19612966A1 Tierische Zellen und Verfahren zur Vermehrung von Influenzaviren Animal cells and processes for replication of influenza viruses
10/02/1997	CA2250576A1 Monocyte chemotactic protein-5 materials and methods
10/02/1997	CA2250241A1 Arylamino fused pyridines and pyrimidines
10/02/1997	CA2250166A1 Soluble divalent and multivalent heterodimeric analogs of proteins
10/02/1997	CA2250058A1 Recombinant pox virus encoding myelin protein for therapy
10/02/1997	CA2249985A1 Tumour necrosis factor alpha convertase
10/02/1997	CA2249652A1 Method of treating common cold or allergic rhinitis
10/02/1997	CA2249455A1 Precursors of catalytic antibodies

1 ... 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 ... 1172